Logo image
Sign in
Back
Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak
Other   Peer reviewed

Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak

Jan Holubar, Moglie Le Quintrec, Hind Letaief, Jean Luc Faillie, Yves-Marie Pers and Christian Jorgensen
Annals of the Rheumatic Diseases, pp.e56-e56
11/03/2021
DOI: https://doi.org/10.1136/annrheumdis-2020-217919
PMID: 32513650

Abstract

Epidemiology Hydroxychloroquine Lupus erythematosus Systemic Epidemiology
The emergence and spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the resulting COVID-19 disease, have had a tremendous impact on public health and the world economy. Thus far, COVID-19 does not appear to be more severe in immunocompromised patients, but relevant data are scarce.
url
Find in HALView

Metrics

1 Record Views

Details

Logo image